Historical record - last NADAC publication: 8/18/2021
Product Information
ZOLPIDEM TART 3.5 MG TABLET SL is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $6.7952 per EA under NDC 43386076130. Its NADAC has been published 125 times since Jul 17, 2019.
Strength
3.5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386076130
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
8/18/2021
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204299On Market Since
3/22/2016
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has been published 125 times since Jul 17, 2019, and over the history we have for it it has risen 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7952 per EA |
|---|---|
| All-time high | $6.7952 (Dec 1, 2021) |
| All-time low | $5.0403 (Jul 17, 2019) |
| Median price | $6.4120 |
| Average price | $6.0940 |
| Largest weekly change | +24.0% (Aug 21, 2019) |
| Weeks tracked | 125 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the zolpidem tartrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZOLPIDEM TART 3.5 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TART 3.5 MG TABLET SL, manufactured by Lupin Pharmaceuticals Inc., is $6.7952 per EA (NDC 43386076130), effective Dec 1, 2021.
How has the price of ZOLPIDEM TART 3.5 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has risen 34.8%. It has been tracked across 125 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TART 3.5 MG TABLET SL?
Since Jul 17, 2019, the NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has ranged from a low of $5.0403 (Jul 17, 2019) to a high of $6.7952 (Dec 1, 2021), with a median of $6.4120 per EA.
Are there cheaper alternatives to ZOLPIDEM TART 3.5 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZOLPIDEM TART 3.5 MG TABLET SL, so no direct lower-cost alternative is listed.
Who manufactures ZOLPIDEM TART 3.5 MG TABLET SL?
ZOLPIDEM TART 3.5 MG TABLET SL (NDC 43386076130) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification